FDA Adverse Event Malfunction Summary report: N

OT VERIO PRO METER

MDR report key: 2537604 · Received April 17, 2012

Report

Report Number
3008382007-2012-01551
Event Type
Malfunction
Date Received
April 17, 2012
Report Date
April 2, 2012
Manufacturer
LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
Product Code
NBW
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
BE
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DEVICE EVALUATION: THE TEST STRIPS INVOLVED WITH THIS COMPLAINT (LOT # 3230777) AS WELL AS TWO DIFFERENT VIALS (LOT #S 3273091 AND 3157522) HAVE BEEN RETURNED (B)(4) 2012 AND EVALUATED BY PRODUCT ANALYSIS (PA) ON (B)(4) 2012 WITH THE FOLLOWING FINDINGS: THE ALLEGED ISSUE WAS CONFIRMED WHEN TESTING LOT# 3230777 WITH CONTROL SOLUTION DURING INVESTIGATION. ER4 WAS OBSERVED WITH LOT #3273091 WHEN TESTING WITH CONTROL SOLUTION. WITH LOT #3157522 AN ER4 WAS OBSERVED (WHILE TESTING WITH CONTROL SOLUTION) AND WAS ALSO FOUND TO HAVE EXTRA TEST STRIPS IN THE VIAL. IF LIFESCAN OBTAINS ADDITIONAL INFORMATION REGARDING THIS COMPLAINT, A FOLLOW UP REPORT WILL BE SUBMITTED. AT THIS TIME, LIFESCAN CONSIDERS THIS MATTER CLOSED.

Description of Event or Problem · 1

ON (B)(6) 2012, THE LAY-USER/PATIENT CONTACTED LIFESCAN FROM (B)(4) ALLEGING AN ERROR 4 MESSAGE ISSUE WITH A ONE TOUCH VERIO PRO METER. THE PATIENT DID NOT ALLEGE ANY HARM OR INJURY BECAUSE OF THE REPORTED ISSUE. THE ALLEGED ISSUE WAS NOT RESOLVED WITH TROUBLESHOOTING. BASED ON THE INFORMATION PROVIDED, THIS COMPLAINT IS BEING REPORTED DUE TO THE FOLLOWING CONCLUSION: THE PATIENT CLAIMED THAT THE METER HAD AN ERROR 4 MESSAGE ISSUE. THERE IS NO EVIDENCE, HOWEVER, THAT THE ALLEGED ISSUE CONTRIBUTED TO A SERIOUS INJURY. THE PATIENT DID NOT REPORT ANY SYMPTOMS, TREATMENT, OR BLOOD GLUCOSE VALUES SUGGESTIVE OF A SERIOUS INJURY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 OT VERIO PRO METER GLUCOSE MONITORING SYS/KIT NBW LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL

Patients

Seq Age Sex Outcome Treatment
1 54 YR